DermTech, Inc. DMTKQ
0.00
0.00
NaN
as of 13 Aug
- Market cap
- $3.3M
- P/E
- 0.0×
Follow DMTKQ
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Mar '19 | Dec '18 | Mar '18 | Dec '17 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
P/S ratio |
3.54 | 3.77 | 38.55 | 93.60 | 25.82 | — | 0.00 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
P/Operating CF |
(4.26) | (2.58) | (20.12) | (81.64) | (14.29) | — | 9.20 | — | — | — |
P/B ratio |
0.95 | 0.41 | 1.99 | 8.91 | 6.96 | — | 0.00 | — | — | — |
Price to Tangible BV |
0.95 | 0.41 | 1.99 | 8.91 | 6.96 | — | 0.00 | — | — | — |
EV/Sales |
(0.11) | (4.92) | 19.54 | 83.08 | 21.40 | — | 0.00 | — | — | — |
EV/EBITDA |
0.02 | 0.63 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
EV/Operating CF |
0.02 | 0.75 | (3.72) | (17.04) | (4.05) | — | (60.35) | — | — | — |
EV/FCF |
0.02 | 0.72 | (3.57) | (16.02) | (4.00) | — | (60.35) | — | — | — |
Quick Ratio |
4.35 | 8.34 | 18.81 | 12.03 | 2.81 | 0.02 | 0.51 | 10.74 | 0.00 | 0.14 |
Current Ratio |
4.59 | 8.70 | 19.11 | 12.33 | 3.00 | 0.05 | 0.51 | 12.97 | 6.00 | 0.14 |
Net Debt/EBITDA |
0.57 | 1.11 | 3.03 | 1.78 | 0.99 | 0.02 | 0.56 | 1.47 | — | 250.00 |
Debt/Assets |
0.03% | 0.03% | 0.11% | 2.69% | 0.00% | 0.00% | 9.11% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | (0.10) | 0.00 | — | 0.00 |
Asset Turnover |
0.09 | 0.06 | 0.07 | 0.13 | 0.22 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.76 | 0.82 | 0.79 | 0.79 | 0.88 | (0.47) | 0.76 | (0.44) | (0.85) | (22.00) |
Capex/Depreciation |
(0.17) | (0.68) | (0.89) | (3.94) | (0.10) | — | (0.01) | — | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| (106.46%) | (64.46%) | (53.74%) | (98.15%) | (230.20%) | (532.11%) | 5,636.06% | 34.10% | 0.00% | (1.03%) | |
| (62.28%) | (51.81%) | (49.25%) | (82.91%) | (131.35%) | 10.43% | (13.12%) | 0.58% | 1.17% | (0.05%) | |
ROIC |
(4,806.29%) | (1,182.97%) | (1,040.52%) | 0.00% | 0.00% | (24.88%) | 0.00% | (4.21%) | — | 0.00% |
Return on Tangible Assets |
(189.31%) | (92.04%) | (34.79%) | (56.83%) | (162.27%) | (63.96%) | 204.62% | 170.77% | 1,712.80% | 0.07% |
Average Days of Receivables |
61.66 | 104.89 | 118.61 | 91.79 | 73.78 | — | 86.69 | — | — | — |
Research and Development Expense of Revenue |
99.63% | 165.67% | 137.36% | 89.94% | 74.23% | — | 84.11% | — | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
580.39% | 652.71% | 527.21% | 508.07% | 450.89% | — | 258.85% | — | — | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
121.37% | 130.42% | 112.15% | 84.44% | 38.76% | — | 37.35% | — | — | — |
Graham Net Nets |
(0.06) | 1.21 | 0.47 | 0.11 | 0.13 | — | (0.11) | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
Earnings Yield |
(189.16%) | (213.74%) | (17.09%) | (6.44%) | (23.26%) | — | (0.64%) | — | — | — |
Free Cash Flow Yield |
(143.73%) | (180.29%) | (14.20%) | (5.54%) | (20.72%) | — | (1.52%) | — | — | — |
Revenue per Share |
0.47 | 0.48 | 0.41 | 0.35 | 0.48 | 0.00 | 0.55 | 0.00 | — | 0.00 |
Operating CF per Share |
(2.36) | (3.17) | (2.15) | (1.69) | (2.54) | (0.09) | (1.72) | (0.08) | 0.00 | 0.00 |
Capex per Share |
(0.03) | (0.11) | (0.09) | (0.11) | (0.03) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(2.39) | (3.28) | (2.24) | (1.80) | (2.57) | (0.09) | (1.73) | (0.08) | 0.00 | 0.00 |
Cash per Share |
1.71 | 4.20 | 7.80 | 3.76 | 2.19 | 0.01 | 1.08 | 0.10 | — | 0.01 |
Shareholders Equity per Share |
1.75 | 4.41 | 7.95 | 3.64 | 1.78 | 0.97 | (1.21) | 1.06 | — | 0.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Book value per Share |
1.75 | 4.41 | 7.95 | 3.64 | 1.78 | 0.97 | (1.21) | 1.06 | — | 0.01 |
Free Cash Flow |
(77.88) | (98.56) | (64.83) | (30.52) | (18.00) | (0.44) | (7.62) | (0.37) | (0.73) | 0.00 |
Working Capital |
48.31 | 120.40 | 220.64 | 61.46 | 11.43 | (1.48) | (5.10) | 0.50 | 0.05 | (0.15) |
Capital Expenditures |
(0.90) | (3.30) | (2.72) | (1.83) | (0.21) | — | (0.01) | — | 0.00 | — |
Net Current Asset Value |
(3.00) | 66.32 | 214.21 | 58.94 | 11.43 | (7.36) | (5.62) | (141.35) | (4.98) | (0.15) |
EV/EBIT |
0.02 | 0.60 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
Capex to Sales |
0.06 | 0.23 | 0.23 | 0.31 | 0.06 | — | 0.00 | — | 0.00 | — |
Net Profit Margin |
(659.57%) | (803.71%) | (661.72%) | (619.83%) | (598.39%) | 0.00% | (409.66%) | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.07 | 0.76 | 0.67 | 0.17 | 2.12 | — | 4.83 | — | 0.00 | — |
Cash ROIC |
(72.49%) | (39.31%) | (14.64%) | (24.64%) | (67.36%) | (8.84%) | 9,093.02% | (6.85%) | 0.00% | 4.66% |
Accounts Receivable Turnover |
4.53 | 3.62 | 4.44 | 5.45 | 5.34 | — | 3.88 | — | — | — |
Accounts Payable Turnover |
7.70 | 5.24 | 4.74 | 3.76 | 2.11 | 2.19 | 16.58 | 17.30 | — | 0.01 |
Inventory Turnover |
10.88 | 12.40 | 36.18 | 86.06 | 88.11 | 0.00 | 70.05 | 0.00 | — | 0.00 |
Average Days of Payables |
36.06 | 63.65 | 99.51 | 95.99 | 177.75 | 280.89 | 39.74 | 36.83 | — | 16,425.00 |
Days of Inventory on Hand |
24.40 | 46.23 | 16.58 | 6.35 | 3.87 | 0.00 | 5.56 | 0.00 | — | 0.00 |
Average Receivables |
3.38 | 4.01 | 2.66 | 1.08 | 0.63 | — | 0.63 | — | — | — |
Average Payables |
1.95 | 2.65 | 2.23 | 1.59 | 1.57 | 0.90 | 0.16 | 0.02 | — | 0.02 |
Average Inventory |
1.38 | 1.12 | 0.29 | 0.07 | 0.04 | — | 0.04 | — | — | — |
Average Assets |
162.00 | 225.19 | 159.04 | 44.00 | 15.33 | 9.05 | 76.28 | 146.41 | 73.06 | 0.19 |
Average Common Equity |
94.76 | 181.03 | 145.77 | 37.16 | 8.74 | (0.18) | (0.18) | 2.51 | — | 0.01 |
Columns are period end dates